• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

CitiusTech Launches Generative AI Quality & Trust Solution

by Jasmine Pennic 02/16/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Bain Capital PE Makes Strategic Investment in CitiusTech

What You Should Know:

– CitiusTech, a healthcare technology provider, has unveiled a groundbreaking solution to address the reliability, quality, and trust concerns surrounding Generative AI (Gen AI) in healthcare.

– This industry-first offering aims to empower healthcare organizations to confidently adopt and scale Gen AI applications, unlocking their transformative potential.

Gen AI Quality & Trust Solution

Over 80% of Gen AI projects face delays due to lack of trust in their reliability and compliance. CitiusTech’s Gen AI Quality & Trust solution tackles this challenge by prioritizing trust, quality, and reliability. CitiusTech’s Gen AI Quality & Trust Solutions fully integrate into existing MLOps, DataOps and Quality Management Solutions, and anchors to healthcare use cases and outcomes.

Key features include:

  • Software-based framework: Coupled with consulting, implementation, and support services.
  • Automated design & decision-making: Provides pre-packaged measures and automated validation.
  • Healthcare-specific metrics: Over 70 metrics across 7 dimensions (accuracy, bias, fairness, etc.).
  • Beta-tested by multiple clients: Ensures real-world effectiveness and user feedback incorporated.

“At present, there are no established technology or platform agnostic solutions that measure quality and trust of healthcare Gen AI solutions, end-to-end. Approaches used in building and evaluating LLMs, and foundation models are useful, but have not been designed for healthcare,” said Sridhar Turaga, SVP – Data and Analytics, CitiusTech. “Our Gen AI Quality & Trust Solution is the first systematic approach in healthcare to quantitatively measure, verify and monitor Gen AI solutions. This solution also synthesizes and builds on work by AI researchers, platform players, industry forums and regulatory bodies. We go beyond pure math or tech and contextualize everything to healthcare context.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Generative AI

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |